News
Jayeeta Chatterjee has joined Sandoz as Head - HCM Transformation (P&O).In a recent LinkedIn post, Chatterjee said, "I'm ...
Sandoz announced the European launch of its Pyzchiva (ustekinumab) autoinjector. This is the first ustekinumab biosimilar in ...
Every investor in Sandoz Group AG (VTX:SDZ) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are individual investors with 52% ownership.
Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...
Sandoz launches ustekinumab biosimilar, Pyzchiva autoinjector in Europe: Basel Saturday, May 24, 2025, 12:00 Hrs [IST] Sandoz, one of the global leaders in generic and biosimilar ...
Misinterpretation of MRI findings by clinicians focused on earlier intervention is leading to increased rates of ...
Crafted entirely in Fleurier, the Tonda PF Micro-Rotor embodies discreet luxury, ultra-thin engineering, and vertical ...
Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug ...
Sandoz completed its long-heralded separation from Novartis on schedule this morning, with its shares trading at CHF 24 on the SIX Swiss Exchange. That valued the newly independent company at CHF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results